Occult Cancer Found in ~5 Percent With Unprovoked VTE

Share this content:
Occult Cancer Found in ~5 Percent With Unprovoked VTE
Occult Cancer Found in ~5 Percent With Unprovoked VTE

TUESDAY, Aug. 22, 2017 (HealthDay News) -- About one in 20 patients with unprovoked venous thromboembolism (VTE) have occult cancer detected within one year, according to a review published online Aug. 22 in the Annals of Internal Medicine.

Nick van Es, M.D., from the Academic Medical Center in Amsterdam, and colleagues estimated the prevalence of occult cancer in patients with unprovoked VTE using data from 10 eligible studies with 2,316 patients.

The researchers found that after VTE diagnosis, the 12-month prevalence of cancer was 5.2 percent. Patients who had extensive screening had a higher point prevalence of cancer than those who had more limited screening initially (odds ratio, 2.0; 95 percent confidence interval, 1.2 to 3.4) but not at 12 months (odds ratio, 1.4; 95 percent confidence interval, 0.89 to 2.1). There was a linear increase in cancer prevalence with age, with seven-fold higher prevalence in patients aged 50 years or older versus younger patients (odds ratio, 7.1; 95 percent confidence interval, 3.1 to 16).

"Although an extensive screening strategy initially may detect more cancer cases than limited screening, whether this translates into improved patient outcomes remains unclear," the authors write.

Several authors disclosed financial ties to the pharmaceutical industry.

Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions


Sign up for myCME e-newsletters


More in Home

Amount of Opioids Prescribed After Hospital Discharge Varies

Amount of Opioids Prescribed After Hospital Discharge Varies

45.6 percent of patients using no opioids 24 hours predischarge were prescribed opioids at discharge

Observation Care Cost Saving in Commercially-Insured Patients

Observation Care Cost Saving in Commercially-Insured Patients

Total, out-of-pocket spending considerably lower for observation care; both increased from '09 to '13

Disrupted Sleep Linked to Increased Amyloid- Production

Disrupted Sleep Linked to Increased Amyloid-β Production

Sleep deprivation tied to increased overnight amyloid-β-38, -40, -42 levels by 25 to 30 percent

is free, fast, and customized just for you!

Already a member?

Sign In Now »